Zach Kubo
Real Chemistry
Replay available
Corvus Pharmaceuticals, Inc. (CRVS) Q2 2026 Earnings Call
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) Q2 2026 earnings conference call, held 2026-08-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Leiv Lea
Chief Financial Officer
Richard Miller
Chief Executive Officer
Jeff Jones
Analyst, Oppenheimer & Co.
Cha Cha Young
Analyst, Jefferies
Kevin Peter
Analyst, Ladenburg Thalmann
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Corvus Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:22.499 -- 00:00:24.720 Thank you. 00:00:52.522 -- 00:00:54.744 . . . 00:01:59.155 -- 00:02:01.415 . . . 00:02:39.607 -- 00:02:41.927 . . . 00:03:38.012 -- 00:03:40.292 . . . 00:04:10.502 -- 00:04:12.682 Thank you. 00:04:58.619 -- 00:05:04.320 Good afternoon everyone and thank you for standing by. 00:05:27.800 -- 00:05:32.364 Welcome to the Corvus Pharmaceuticals Second Quarter 2026 00:05:32.364 -- 00:05:36.647 Business Update and Financial Results Conference Call. 00:05:36.647 -- 00:05:40.790 At this time, all participants are in listen-only mode. 00:05:40.790 -- 00:05:45.634 Later, we will conduct a question-and-answer session, and instructions will follow at 00:05:45.634 -- 00:05:50.658 that time. It is now my pleasure to turn the call over to Zach Kubo 00:05:50.658 -- 00:05:54.879 of Real Chemistry. Please go ahead, sir. 00:05:55.061 -- 00:05:58.273 Thank you, Operator, and good afternoon, everyone. 00:05:58.273 -- 00:06:03.737 Thanks for joining us for the Corvus Pharmaceuticals Second Quarter 2026 Business Update 00:06:03.737 -- 00:06:08.440 and Financial Results Conference Call. On the call to discuss the results and business 00:06:08.440 -- 00:06:14.423 updates are Richard Miller, Chief Executive Officer, Leiv Lea, Chief Financial Officer, 00:06:14.423 -- 00:06:19.427 Jeff Arcara, Chief Business Officer, and Ben Jones, Senior Vice President of 00:06:19.427 -- 00:06:21.688 Pharmaceutical Development. 00:06:21.688 -- 00:06:25.371 The executive team will open the call with some prepared remarks followed by a question 00:06:25.371 -- 00:06:30.209 and answer period. I would like to remind everyone that comments made by management today 00:06:30.209 -- 00:06:33.591 and answers to questions will include forward-looking statements. 00:06:33.591 -- 00:06:3...